ArticleSaudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
Ocular adnexal lymphoma: A single-institution retrospective study.
Article in Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 18 citations in OpenAlex.
- Bilateral Conjunctival Small Lymphocytic Lymphoma Simulating Inflammatory Ocular Surface Disease: A Case Report.Vision (Basel, Switzerland) · 2026Article
- Sustained improvement in survival for primary ocular adnexal lymphoma from 2005 to 2024 by model-based period analysis.Discover oncology · 2026Article
- Non-gastric mucosa-associated lymphoid tissue lymphomas: a narrative review of pathogenesis, diagnosis, and treatment strategies.Annals of translational medicine · 2025Review
- Bilateral eyelid masses and enophthalmos as the initial manifestation of diffuse large B-cell lymphoma: a case report.Journal of medical case reports · 2025Article
- The patient with recurrent periorbital cellulitis: A sinister NK cell tumor lymphoma.American journal of ophthalmology case reports · 2025Article
- Clinical characteristics and outcomes of primary orbital lymphoma.European journal of ophthalmology · 2025Article
- A rare case of primary unilateral conjunctival small lymphocytic lymphoma: A case report.International journal of surgery case reports · 2025Article
- Case Series of Orbital Lymphoma: Cardinal Presentations.Plastic and reconstructive surgery. Global open · 2024Article
- Artificial intelligence and machine learning a new frontier in the diagnosis of ocular adnexal tumors: A review.SAGE open medicine · 2024Review
- Ocular Adnexal Lymphoma: An Ophthalmologist's Perspective from a Single-center Experience.Cancer diagnosis & prognosisArticle
- Primary unilateral conjunctival small lymphocytic lymphoma in a child: Case report and literature review.Oman journal of ophthalmologyArticle
- Non‑Hodgkin's lymphomas of the lacrimal sac: Current insights and future directions (Review).Medicine internationalReview
- The ocular adnexa.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological SocietyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo characterize demographic, clinical, and histopathologic features of ocular adnexal lymphoma (OAL) at a single institution.
methodsRetrospective review of all patients with pathologic diagnosis of OAL between 2015 and 2020.
resultsThere were 133 patients with OAL, with a median age of 65 years (range 23-97) and a slight female predominance (male: female = 1:1.46), (
conclusionIn this largest single-center study of OAL, we found that most OAL were Ann-Arbor Stage IE EMZL, occurring in older patients with a female predominance. Early recurrence was noted in tumors treated with excision and cryotherapy alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.